Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/21/20 → 9/20/23 |
Funding
- Medical Science & Computing, LLC (75N98020D00086 // 75N98020D00086)
- National Cancer Institute (75N98020D00086 // 75N98020D00086)
NU NCI20C06 - Phase II Trial of the Immune Checkpoint Inhibitor Nivolumab in Patients with Recurrent Select Rare CNS Cancers
- Kumthekar, Priya U (PD/PI)
Project: Research project